Skip to content

Effectiveness of patient support programme for the treatment of hepatitis C

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12471415
Enrollment
500
Registered
2006-06-02
Start date
2004-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis C Infections and Infestations Hepatitis C virus

Interventions

All patients who met these criteria randomly chose to be serviced in either of the following two groups: Group 1 with public health nurse consultation in the outpatient clinic. Group 2 was offered pho

Sponsors

Department of Health (Taiwan)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients who have never received interferon and who had at least 2000 copies of HCV ribonucleic acid per ml (RNA/ml) of serum with polymerase chain reaction (PCR) assay, serum aspartate aminotransferase (AST) above the upper limit of normal within six months before entry into study and a liver biopsy result consistent with the diagnosis of chronic hepatitis C.

Exclusion criteria

Exclusion criteria: Patients with: 1. Neutropenia (1.5 times the upper limit of normal 7. Poorly-controlled psychiatric disease 8. Unwilling to receive contraception

Design outcomes

Secondary

MeasureTime frame
1. Serum alanine aminotransferase 2. Aspartate aminotransferase 3. Dropout rate (the number of patients who discontinued treatment prematurely or were lost to follow-up)

Primary

MeasureTime frame
Sustained virologic response (absence of detectable HCV RNA at the end of follow-up with PCR assay)

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026